Methicillin-resistant Staphylococcus aureus (MRSA) is the most commonly cultured bacteria in hand infections. Understanding the most common bacteria involved in hand infections allows appropriate and efficient administration of antibiotics. Delay in treatment may lead to increased morbidity, including stiffness, contracture, and amputation. The purposes of this study are to determine whether the incidence of MRSA in culture-positive hand infections continues to increase and whether MRSA is a risk factor for increased length of stay.
M ethicillin-resistant Staphylococcus aureus (MRSA) has emerged as the most commonly cultured bacteria in hand infections. [1] [2] [3] [4] [5] [6] Published reports have documented the increasing incidence of MRSA in hand infections, with MRSA accounting for 16% of cultures in 2003 and 55% to 73% in 2007. 1, 5 Previous studies have found the infection location, timing, and adequacy of surgical treatment, medical comorbidities, and causative organism to be important factors in determining the morbidity of hand infections. 1, 7, 8 Specifically, MRSA infection has been associated with increased patient morbidity and mortality 9, 10 and increased medical costs. 10, 11 Understanding the most common bacteria involved in hand infections allows appropriate and efficient antibiotic administration. Delay in treatment may lead to increased morbidity, including stiffness, contracture, and possible amputation. 7 O'Malley et al 5 initiated a clinical protocol to aggressively treat all hand infections with a specific empiric antibiotic regimen and demonstrated a decrease in the time to appropriate coverage. A change in the incidence of different bacteria in hand infections may necessitate a change in empiric antibiotic regimens. The purpose of this study is to determine whether the incidence of MRSA in culture positive hand infections continues to increase and to determine whether MRSA is a risk factor for increased length of stay.
Materials and Methods
After institutional review board approval, electronic medical records were queried to identify all patients admitted to an academic urban medical center with the diagnosis of a hand infection between January 1, 2005, and December 31, 2009. The Orthopaedic Department at the authors' institution is the only department responsible for the treatment of hand infections, allowing the authors to capture all hand infections over the study period.
The following International Classification of Diseases, Ninth Edition, codes were used: 681.00, 681.01, 681.02, 682.4, 727.05, 727.9, 883.00, 883.1, 882.01, and 882.00 (cellulitis, abscess, tenosynovitis, and open wounds of the fingers and hands). The following inclusion criteria were used: age between 18 and 89 years; underwent incision and debridement with a culture performed; and medical records were available for review.
Patient demographics, date of admission and discharge, specific bacteria cultured, and presence of polymicrobial infection were recorded. A polymicrobial infection was defined as the presence of 2 or more bacteria in the culture. The patients were grouped by year and then the annual incidence of MRSA was calculated. Negative binomial regression was used to determine whether a trend was found in the incidence of polymicrobial infection and Mann-Whitney nonparametric test was used to determine differences in length of stay. Table 1 ). The second most common pathogen was methicillin-sensitive S aureus (MSSA) (n594; 22.6%), followed by polymicrobial infection (n581; 19.5%).
Patients with polymicrobial infection had an average age of 44.1 years (95% CI, 40.9-47.3 years) compared with an average age of 39.3 years (95% CI, 38.5-40.0 years) (P,.0001) for patients with nonpolymicrobial infections. Of the 81 poly- Patients with MRSA were found to have a mean length of stay of 4.1 days (95% CI, 3.7-4.5 days) compared with non-MRSA infections that had a mean length of stay of 4.5 days (95% CI 3.7-5.3 days) (P5.4). Patients with polymicrobial infections were found to have a mean length of stay of 5.7 days (95% CI, 4.1-7.2) compared to nonpolymicrobial infection with a mean length of stay of 4.0 days (95% CI, 3.6-4.3) (P5.046).
ConClusion
Although MRSA appeared almost immediately after the development of methicillin, 12 the first detailed case reports regarding community-acquired MRSA infections of the hand were published in 2000, with MRSA representing a minority of infections. 13 Recent published incidence rates for MRSA infections in the hand have trended upward from 16% in 2000 to 73% in 2007. 1 Bach et al 1 reviewed culture data from 61 patients who underwent incision and debridement of hand infections and found the incidence of MRSA to be 73%. Wilson and Rinker 6 reviewed 84 patients over a 5-year period and found the incidence of MRSA to be 60%. Interestingly, 2 institutions have offered multiple publications that support this upward trend. Weinzweig and Gonzalez 14 reported a 16.2% incidence of community-acquired MRSA hand infections in the early 1990s. Ten years later, clinicians at the same institution reported an incidence of 73.1%.
1 Similarly, the current authors' institution followed the This study represents the largest series of culture-positive hand infections to be presented in the literature to date and demonstrates that MRSA continues to account for the majority of hand infections at the authors' institution. The Centers for Disease Control and Prevention recommends empiric coverage for MRSA if local prevalence exceeds 10% to 15%. 15 Therefore, empiric treatment aimed at its management continues to be indicated. The current authors' institution empirically treats all patients with vancomycin (clindamycin if vancomycin allergy) as inpatients and with bactrim or clindamycin as outpatients due the local high incidence of MRSA. The generalizability and importance of the recent increase in polymicrobial infections in this study is unknown. Broad-spectrum antibiotics should not be initiated in all patients, but rather clinical judgment used in patients with risk factors for polymicrobial infection, such as rheumatoid arthritis, diabetes mellitus, poor nutritional status, immunocompromised state, and malignancy. 16 Patients who do not improve after adequate incision and debridement and those with increasing white blood cell counts or increased Creactive protein levels despite treatment should also be given consideration for broad-spectrum coverage. The current data suggest that MRSA is less likely to be present in polymicrobial infections than in nonpolymicrobial infections and that the majority (73%) of polymicrobial infections consist of only 2 bacteria.
This study has several limitations. First, as with all retrospective studies, selection bias is possibile; the data collection may not have identified all cases of hand infections over the study period. Second, the cultures were performed in either the operating room or in the emergency department; cultures not performed in the operating room may have been more likely to be subject to contamination and, therefore, confound the results. Third, patient comorbidities and the presence of other illnesses could have affected the patients' length of stay and were not accounted for in this study.
Length of stay was longer in patients with polymicrobial infection compared to those with nonpolymicrobial infection by an average of 1.7 days (P5.04) but was not increased in patients with MRSA (P5.4). To the authors' knowledge, no studies have examined the organism obtained from hand infection culture as a risk factor for increased length of stay. However, MRSA has been identified as a risk factor for increased cost and length of stay in other body systems. 10, 11, 17 It is possible that patients with a compromised immune status, with nutritional deficiencies, and with other severe illnesses would be more likely to have a polymicrobial infection or MRSA than healthy patients 18 19 and, therefore, have an increased length of stay due to these comorbidities rather than the hand infection.
Methicillin-resistant S aureus remains the most common bacteria cultured in hand infections; however, this study also demonstrates evolving data indicating the increasing incidence of polymicrobial infections over the study period. This study represents a snapshot in time at a single institution, and its findings may not be generalizable to other institutions. It is important to note that the authors' findings should not be interpreted to minimize the importance of empiric coverage for MRSA in hand infections. Also, although polymicrobial infections are increasing, empiric broad-spectrum coverage should not be initiated in every patient with a hand infection. Rather, these findings should merely alert physicians to the increasing possibility of polymicrobial infection and allow clinical suspicion and judgment to dictate proper empiric antibiotic treatment.
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